MATUROGÉNESIS EXITOSA POR EXCAVACIÓN PROGRESIVA CON CEMENTO CEM

El tratamiento indirecto de la pulpa, en la pulpa expuesta, con material biológico regenerativo, como el cemento CEM, debería evaluarse en estudios futuros.
Autor
Saeed Asgary
Columnista Experto de SIIC
Institución del autor
Shahid Beheshti University of Medical Sciences, Teherán, Irán
Coautores
Laleh A Marvasti*   
MFDS DDS, Shahid Beheshti University of Medical Sciences, Teherán, Irán*

Palabras clave
apexogénesis, molar inmaduro, tratamiento progresivo, mezcla de cemento enriquecido con calcio, recubrimiento pulpar

Clasificación en siicsalud
Artículos originales > Expertos del Mundo >
página  http://siicsalud.com/dato/casiic.php/153375

Comprar este artículo
Otros artículos escogidos


Especialidades
DI.gif Od.gif   Ci.gif 

Primera edición
18 de enero, 2017
Segunda edición, ampliada y corregida
7 de junio, 2021

Bibliografía del caso clínico
1. Mejare I, Cvek M. Partial pulpotomy in young permanent teeth with deep carious lesions. Endod Dent Traumatol 9(6):238-242, 1993.
2. Nosrat A, Seifi A, Asgary S. Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial. Int J Paediatr Dent 23(1):56-63, 2013.
3. Bjorndal L, Reit C, Bruun G, et al. Treatment of deep caries lesions in adults: randomized clinical trials comparing stepwise vs. direct complete excavation, and direct pulp capping vs. partial pulpotomy. Eur J Oral Sci 118(3):290-297, 2010.
4. Nair PN, Duncan HF, Pitt Ford TR, Luder HU. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial. Int Endod J 41(2):128-150, 2008.
5. Witherspoon DE. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth. J Endod 34(7 Suppl):S25-28, 2008.
6. Mozayeni MA, Milani AS, Marvasti LA, Asgary S. Cytotoxicity of calcium enriched mixture cement compared with mineral trioxide aggregate and intermediate restorative material. Aust Endod J 38(2):70-75, 2012.
7. Asgary S, Eghbal MJ. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial. Acta Odontol Scand 71(1):130-136, 2013.
8. Torabzadeh H, Asgary S. Indirect pulp therapy in a symptomatic mature molar using calcium enriched mixture cement. J Conserv Dent 16(1):83-86, 2013.
9. Asgary S. Mineral trioxide aggregate in dentistry. 1 ed: Springer Berlin Heidelberg, 2014.
10. Tabarsi B, Parirokh M, Eghbal MJ, Haghdoost AA, Torabzadeh H, Asgary S. A comparative study of dental pulp response to several pulpotomy agents. Int Endod J 43(7):565-571, 2010.
11. Witherspoon DE. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth. Pediatr Dent 30(3):220-224, 2008.
12. Asgary S, Fazlyab M, Sabbagh S, Eghbal MJ. Outcomes of different vital pulp therapy techniques on symptomatic permanent teeth: a case series. Iran Endod J 9(4):295-300, 2014.
13. Cox CF, Subay RK, Ostro E, Suzuki S, Suzuki SH. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper Dent 21(1):4-11, 1996.
14. Smail-Faugeron V, Courson F, Durieux P, Muller-Bolla M, Glenny AM, Fron Chabouis H. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev 8:CD003220, 2014.
15. Tabarsi BZ, Mostafazadeh A, Fazli A, Alim Marvasti L, Asgary S. Cytokine release of two endodontic biomaterials. Research Journal of Biological Sciences 7(7):260-264, 2012.
16. Bjorndal L. The caries process and its effect on the pulp: the science is changing and so is our understanding. Pediatr Dent 30(3):192-196, 2008.



Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.

anterior.gif (1015 bytes)

ua40317
Inicio/Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008